DOWNLOAD REQUEST – FCF LIFE SCIENCES RESEARCH SERIES
FCF Life Sciences engages in research on recent financing trends in the Life Sciences sector, i.e. biotechnology, pharma and med-tech. FCF primarily focuses on the latest activities in the equity capital markets: Venture Capital, Initial Public Offerings (IPO) and Equity Valuations.
The findings are regularly published in:
NEWS & PRESS
Venture Capital Sentiment Tracker – October 2023
October 2023: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 10/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 10/2023”. The Monitor is a monthly published overview of venture capital trends in the European
Munich-based Financing Specialist FCF Fox Corporate Finance advises Dutch Agricultural Technology Innovator In Ovo in a pivotal funding round of EUR 40 Million.
PRESS RELEASE Munich-based Financing Specialist FCF Fox Corporate Finance advises Dutch Agricultural Technology Innovator In Ovo in a pivotal funding round of EUR 40 Million. Munich, November 6, 2023 – FCF Fox Corporate Finance, a
FCF Biotech Venture Capital Monitor – USA 09/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 09/2023”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
Venture Capital Sentiment Tracker – September 2023
September 2023: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend
Venture Capital Sentiment Tracker – October 2023
October 2023: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 10/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 10/2023”. The Monitor is a monthly published overview of venture capital trends in the European
Munich-based Financing Specialist FCF Fox Corporate Finance advises Dutch Agricultural Technology Innovator In Ovo in a pivotal funding round of EUR 40 Million.
PRESS RELEASE Munich-based Financing Specialist FCF Fox Corporate Finance advises Dutch Agricultural Technology Innovator In Ovo in a pivotal funding round of EUR 40 Million. Munich, November 6, 2023 – FCF Fox Corporate Finance, a
FCF Biotech Venture Capital Monitor – USA 09/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 09/2023”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
Venture Capital Sentiment Tracker – September 2023
September 2023: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 09/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 09/2023”. The Monitor is a monthly published overview of venture capital trends in the European
Venture Capital Sentiment Tracker – October 2023
October 2023: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 10/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 10/2023”. The Monitor is a monthly published overview of venture capital trends in the European
Munich-based Financing Specialist FCF Fox Corporate Finance advises Dutch Agricultural Technology Innovator In Ovo in a pivotal funding round of EUR 40 Million.
PRESS RELEASE Munich-based Financing Specialist FCF Fox Corporate Finance advises Dutch Agricultural Technology Innovator In Ovo in a pivotal funding round of EUR 40 Million. Munich, November 6, 2023 – FCF Fox Corporate Finance, a
FCF Biotech Venture Capital Monitor – USA 09/2023 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 09/2023”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
